These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 14728813)

  • 21. Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates.
    Barnes B; Boden SD; Louis-Ugbo J; Tomak PR; Park JS; Park MS; Minamide A
    Spine (Phila Pa 1976); 2005 May; 30(10):1127-33. PubMed ID: 15897825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo evaluation of bone marrow stromal-derived osteoblasts-porous calcium phosphate ceramic composites as bone graft substitute for lumbar intervertebral spinal fusion.
    Kai T; Shao-qing G; Geng-ting D
    Spine (Phila Pa 1976); 2003 Aug; 28(15):1653-8. PubMed ID: 12897487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2000 Young Investigator Research Award winner. Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusion.
    Grauer JN; Patel TC; Erulkar JS; Troiano NW; Panjabi MM; Friedlaender GE
    Spine (Phila Pa 1976); 2001 Jan; 26(2):127-33. PubMed ID: 11154530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of fusion rate induced by different dosages of Escherichia coli-derived recombinant human bone morphogenetic protein-2 using hydroxyapatite carrier.
    Lee JH; Yu CH; Yang JJ; Baek HR; Lee KM; Koo TY; Chang BS; Lee CK
    Spine J; 2012 Mar; 12(3):239-48. PubMed ID: 22341396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of platelet-rich plasma and bone marrow on murine posterolateral lumbar spine arthrodesis with bone morphogenetic protein.
    Rao RD; Gourab K; Bagaria VB; Shidham VB; Metkar U; Cooley BC
    J Bone Joint Surg Am; 2009 May; 91(5):1199-206. PubMed ID: 19411469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanocomposite therapy as a more efficacious and less inflammatory alternative to bone morphogenetic protein-2 in a rodent arthrodesis model.
    Hsu WK; Polavarapu M; Riaz R; Roc GC; Stock SR; Glicksman ZS; Ghodasra JH; Hsu EL
    J Orthop Res; 2011 Dec; 29(12):1812-9. PubMed ID: 21590717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effects of High-Dose Parathyroid Hormone Treatment on Fusion Outcomes in a Rabbit Model of Posterolateral Lumbar Spinal Fusion Alone and in Combination with Bone Morphogenetic Protein 2 Treatment.
    Holmes CA; Ishida W; Elder BD; Lo SL; Chen YA; Kim E; Locke J; Taylor M; Witham TF
    World Neurosurg; 2018 Jul; 115():e366-e374. PubMed ID: 29678698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Posterolateral lumbar fusion using Escherichia coli-derived rhBMP-2/hydroxyapatite in the mini pig.
    Kong CB; Lee JH; Baek HR; Lee CK; Chang BS
    Spine J; 2014 Dec; 14(12):2959-67. PubMed ID: 24937799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strut allograft union and remodeling using rhBMP-2 in a spinal corpectomy model.
    White KK; Bawa M; Ahn JS; Farnsworth CL; Faro FD; Mahar AT; Wedemeyer M; Garfin SR; Newton PO
    Spine (Phila Pa 1976); 2005 Jun; 30(12):1386-95. PubMed ID: 15959367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early-term and mid-term histologic events during single-level posterolateral intertransverse process fusion with rhBMP-2/collagen carrier and a ceramic bulking agent in a nonhuman primate model: implications for bone graft preparation.
    Khan SN; Toth JM; Gupta K; Glassman SD; Gupta MC
    J Spinal Disord Tech; 2014 Jun; 27(4):212-9. PubMed ID: 23073151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. rhBMP-2 enhancement of posterolateral spinal fusion in a rabbit model in the presence of concurrently administered doxorubicin.
    Singh K; Smucker JD; Ugbo JL; Tortolani PJ; Tsai L; Fei Q; Kuh S; Rumi M; Heller JG; Boden SD; Yoon ST
    Spine J; 2007; 7(3):326-31. PubMed ID: 17482116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of recombinant human bone morphogenetic protein-2 in an experimental model of spinal fusion in a radiated area.
    Ames CP; Smith JS; Preul MC; Crawford NR; Kim GE; Nottmeier E; Chamberlain R; Speiser B; Sonntag VK; Dickman CA
    Spine (Phila Pa 1976); 2005 Dec; 30(23):2585-92. PubMed ID: 16319743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Video-assisted lateral intertransverse process arthrodesis. Validation of a new minimally invasive lumbar spinal fusion technique in the rabbit and nonhuman primate (rhesus) models.
    Boden SD; Moskovitz PA; Morone MA; Toribitake Y
    Spine (Phila Pa 1976); 1996 Nov; 21(22):2689-97. PubMed ID: 8961457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion.
    Martin GJ; Boden SD; Titus L
    Spine (Phila Pa 1976); 1999 Nov; 24(21):2188-93; discussion 2193-4. PubMed ID: 10562982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Marshall R. Urist Young Investigator Award. Gene expression during autograft lumbar spine fusion and the effect of bone morphogenetic protein 2.
    Morone MA; Boden SD; Hair G; Martin GJ; Racine M; Titus L; Hutton WC
    Clin Orthop Relat Res; 1998 Jun; (351):252-65. PubMed ID: 9646769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of fibronectin on osteoinductive capability of fresh iliac bone marrow aspirate in posterolateral spinal fusion in rabbits.
    Koga A; Tokuhashi Y; Ohkawa A; Nishimura T; Takayama K; Ryu J
    Spine (Phila Pa 1976); 2008 May; 33(12):1318-23. PubMed ID: 18496343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
    Dimar JR; Glassman SD; Burkus KJ; Carreon LY
    Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancing effects of a prostaglandin EP4 receptor agonist on recombinant human bone morphogenetic protein-2 mediated spine fusion in a rabbit model.
    Namikawa T; Terai H; Hoshino M; Kato M; Toyoda H; Yano K; Nakamura H; Takaoka K
    Spine (Phila Pa 1976); 2007 Oct; 32(21):2294-9. PubMed ID: 17906568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purified bovine BMP extract and collagen for spine arthrodesis: preclinical safety and efficacy.
    Damien CJ; Grob D; Boden SD; Benedict JJ
    Spine (Phila Pa 1976); 2002 Aug; 27(16 Suppl 1):S50-8. PubMed ID: 12205421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow enhances the performance of rhBMP-2 in spinal fusion: a rodent model.
    Bae HW; Zhao L; Kanim LE; Wong P; Marshall D; Delamarter RB
    J Bone Joint Surg Am; 2013 Feb; 95(4):338-47. PubMed ID: 23426768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.